<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cellular <z:mpath ids='MPATH_3'>apoptosis</z:mpath> susceptibility (chromosome segregation 1-like, CSE1L) gene maps to chromosomal region 20q13.13, a region frequently amplified in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the roles played by CSE1L in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> by examining CSE1L expression and clinico-pathological parameters in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and investigating the effect of CSE1L on the viability, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and migration of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>RT-PCR showed that CSE1L <z:chebi fb="2" ids="33699">mRNA</z:chebi> was over-expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>CSE1L <z:mpath ids='MPATH_63'>depletion</z:mpath> by knock-down with CSE1L-specific siRNA significantly <z:mp ids='MP_0010831'>reduced viability</z:mp> in HCT116 cells (p = 0.004) and SW480 cells (p = 0.003) whilst significantly increasing the proportion of apoptotic HCT116 cells (p &lt; 0.001) and SW480 cells (p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, CSE1L <z:mpath ids='MPATH_63'>depletion</z:mpath> significantly reduced the adhesive capacity of HCT116 (p = 0.003) and SW480 cells (p = 0.004) </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis by qRT-PCR following CSE1L siRNA treatment of HCT116 and SW480 cells showed significant modulation of key apoptotic (p53, p73 and BAK) and adhesive (E-cadherin, Ep-CAM and ICAM-1) molecules </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemistry of a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue microarray showed that CSE1L had a significantly increased level in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal epithelium (p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>There were significant decreases in both nuclear (p = 0.006) and cytoplasmic (p = 0.003) staining of CSE1L in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (stage 3 tumours) compared with lymph node-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (stage 1 and 2 tumours) </plain></SENT>
<SENT sid="8" pm="."><plain>In lymph node-negative patients, poor survival was associated with increased CSE1L cytoplasmic expression (p = 0.042) </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that CSE1L is associated with viability and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and invasion, thus implicating CSE1L in the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Copyright Â© 2012 Pathological Society of Great Britain and Ireland </plain></SENT>
<SENT sid="11" pm="."><plain>Published by John Wiley &amp; Sons, Ltd </plain></SENT>
</text></document>